| Engineered allogeneic T cells decoupling T-cell-receptor and CD3 signalling enhance the antitumour activity of bispecific antibodies E Kapetanovic, CR Weber, M Bruand, D Pöschl, J Kucharczyk, E Hirth, ... Nature Biomedical Engineering, 1-17, 2024 | | 2024 |
